Cystaran
Total Payments
$913,538
Transactions
197
Doctors
109
Companies
1
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2022 | $855,281 | 39 | 32 |
| 2021 | $437.73 | 17 | 13 |
| 2020 | $11,180 | 38 | 35 |
| 2019 | $27,373 | 40 | 27 |
| 2018 | $733.75 | 7 | 6 |
| 2017 | $18,532 | 56 | 24 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $854,387 | 5 | 93.5% |
| Honoraria | $24,800 | 10 | 2.7% |
| Consulting Fee | $12,900 | 4 | 1.4% |
| Grant | $10,000 | 2 | 1.1% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $5,000 | 2 | 0.5% |
| Food and Beverage | $3,310 | 139 | 0.4% |
| Travel and Lodging | $3,078 | 7 | 0.3% |
| Education | $61.95 | 28 | 0.0% |
Payments by Type
Research
$854,387
5 transactions
General
$59,150
192 transactions
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| Usability Study of Cystaran Eye Drops in New Bottle in Cystinosis Subjects with Corneal Cystine Crystal Accumulation | Leadiant Biosciences, Inc. | $797,200 | 0 |
| Prospective Cohort Study to Describe Practice Patterns and Outcomes in Pediatric Patients (Chronic Kidney Disease, Dialysis and Transplant) with Cystinosis | Leadiant Biosciences, Inc. | $57,187 | 0 |
Top Doctors Receiving Payments for Cystaran
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| Unknown | — | Houston, TX | $864,387 | 7 |
| , MD | Ophthalmology | Euclid, OH | $14,637 | 5 |
| , MD, PHD | Pediatric Nephrology | Atlanta, GA | $6,292 | 4 |
| , MD | Pediatric Nephrology | Houston, TX | $4,880 | 4 |
| , M.D | Nephrology | Wilmington, DE | $4,842 | 13 |
| , M.D | Cornea and External Diseases Specialist | Irvine, CA | $4,400 | 2 |
| Brian Schreiber | — | Neenah, WI | $4,100 | 2 |
| , MD | Ophthalmology | Ann Arbor, MI | $3,643 | 7 |
| , M.D | Pediatrics | San Diego, CA | $2,700 | 1 |
| , MD | Ophthalmology | Los Angeles, CA | $550.00 | 1 |
| , MD | Pediatric Nephrology | Birmingham, AL | $212.00 | 2 |
| , M.D | Pediatrics | Phoenix, AZ | $121.96 | 7 |
| , MD | Pediatrics | El Paso, TX | $114.07 | 4 |
| , M.D | Ophthalmology | Spokane, WA | $76.80 | 2 |
| , MD | Pediatric Nephrology | San Antonio, TX | $72.93 | 4 |
| , M.D | Internal Medicine | Munster, IN | $68.64 | 2 |
| , M.D | Nephrology | San Antonio, TX | $60.25 | 3 |
| , M.D | Nephrology | San Antonio, TX | $59.56 | 3 |
| , MD | Pediatric Nephrology | Philadelphia, PA | $57.08 | 2 |
| , M.D | Nephrology | Grand Rapids, MI | $50.95 | 1 |
| , MD | Cornea and External Diseases Specialist | Kansas City, MO | $49.16 | 2 |
| Arthur Jung | Optometrist | New York, NY | $48.46 | 2 |
| , M.D | Student in an Organized Health Care Education/Training Program | Phoenix, AZ | $45.24 | 2 |
| , D.O | Ophthalmology | Detroit, MI | $45.07 | 4 |
| , MD | Pediatric Ophthalmology and Strabismus Specialist | West Bloomfield, MI | $45.07 | 4 |
Ad
Manufacturing Companies
- Leadiant Biosciences, Inc. $913,538
Product Information
- Type Drug
- Total Payments $913,538
- Total Doctors 109
- Transactions 197
About Cystaran
Cystaran is a drug associated with $913,538 in payments to 109 healthcare providers, recorded across 197 transactions in the CMS Open Payments database. The primary manufacturer is Leadiant Biosciences, Inc..
Payment data is available from 2017 to 2022. In 2022, $855,281 was paid across 39 transactions to 32 doctors.
The most common payment nature for Cystaran is "Unspecified" ($854,387, 93.5% of total).
Cystaran is associated with 2 research studies, including "Usability Study of Cystaran Eye Drops in New Bottle in Cystinosis Subjects with Corneal Cystine Crystal Accumulation" ($797,200).